<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01325064</url>
  </required_header>
  <id_info>
    <org_study_id>GRS 498/A/10</org_study_id>
    <nct_id>NCT01325064</nct_id>
  </id_info>
  <brief_title>Blood Pressure and Subclinical Organ Damage</brief_title>
  <acronym>Vasorisk</acronym>
  <official_title>Central and Peripheral Blood Pressure and Its Relation With Vascular Target Organ Damage in Carotid, Retinal and Arterial Stiffness. Developed and Validation of a Tool</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion y Formacion en Ciencias de la Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Castilla-Le√≥n Health Service</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carlos III Health Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion para la Investigacion y Formacion en Ciencias de la Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The purpose of this study is to analyze the relationship between central and&#xD;
      peripheral blood pressure (clinic and ambulatory) with vascular structure and function,&#xD;
      assessed by carotid intima-media thickness (IMT), artery venous retinal index, pulse wave&#xD;
      velocity (PWV) and ankle-brachial index in patients with diabetes type 2 and without diabetes&#xD;
      type 2. Develop and validate a software to measure the retinal vessels and to estimate&#xD;
      arterio-venous index automatically.&#xD;
&#xD;
      Methods/design: The investigators will Perform a coss-sectional study with control group,&#xD;
      with follow-up of 4 years in primary care. The study population will be diabetic type 2&#xD;
      patients with a control group without diabetes mellitus. The investigators will include by&#xD;
      consecutive sampling 300 patients between 34 and 75 and without previous cardiovascular&#xD;
      disease, half of each group. Main measurements: age, sex, height, weight and waist&#xD;
      circumference. Lipids, creatinine, microalbuminuria, blood glucose, HbA1C, insulin,&#xD;
      fibrinogen, hs-CRP and markers of endothelial dysfunction. Clinic and ambulatory blood&#xD;
      pressure (MAPA). Ultrasonography to assess carotid IMT, retinography to assess arterio-venous&#xD;
      ratio. ECG to evaluate left ventricular hypertrophy, ankle-brachial index and morphology&#xD;
      analysis (PWA) and pulse wave velocity (PWV) in Sphigmocor System.&#xD;
&#xD;
      Discussion: The investigators provide information regarding various parameters derived from&#xD;
      MAPA and pulse wave analysis of with target organ damage, especially with the vascular&#xD;
      structure and function assessed by IMT and PWV and endothelial dysfunction in patients with&#xD;
      diabetes type 2 and without this disease. The investigators also hope to demonstrate the&#xD;
      usefulness of the tool developed for automatic evaluation of retinal vascularization in the&#xD;
      early detection of abnormalities of vascular structure and function and the prognosis of&#xD;
      cardiovascular disease in the medium term.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>subclinical organ damage</measure>
    <time_frame>december, 1 2013</time_frame>
  </primary_outcome>
  <enrollment type="Actual">500</enrollment>
  <condition>Diabetes Mellitus</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be diabetic type 2 patients with a control group without diabetes&#xD;
        mellitus. We will include by consecutive sampling 300 patients between 34 and 75 and&#xD;
        without previous cardiovascular disease, half of each group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patients aged 34 years or more but less than 75 years, with and without type 2&#xD;
             diabetes.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patients who fail to meet the requirements of the protocol (mental disorders and / or&#xD;
             cognitive uncooperative, education and understanding limitations),&#xD;
&#xD;
          -  Patients with ischemic heart disease, cerebrovascular disease or other atherosclerotic&#xD;
             disease&#xD;
&#xD;
          -  Patients who are participating or will participate in a clinical trial during the&#xD;
             study&#xD;
&#xD;
          -  Patients with serious comorbidity that might endanger his life in the next 12 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>34 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuel A Gomez</last_name>
    <role>Study Director</role>
    <affiliation>Infoslaud Fundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Luis Garcia Ortiz</name>
      <address>
        <city>Salamanca</city>
        <zip>37003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>March 27, 2011</study_first_submitted>
  <study_first_submitted_qc>March 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2011</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Carotid Artery Diseases</keyword>
  <keyword>Blood Pressure</keyword>
  <keyword>Blood Pressure Monitoring, Ambulatory</keyword>
  <keyword>Peripheral Vascular Diseases</keyword>
  <keyword>Retinal Vessels</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

